HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $25 Price Target

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Ocular Therapeutix (NASDAQ: OCUL) and maintained a price target of $25 for the company's stock.